Clinical Trial Detail

NCT ID NCT02532010
Title Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

acute myeloid leukemia

Therapies

Decitabine + Pacritinib

Cytarabine + Pacritinib

Age Groups: senior

No variant requirements are available.